Funding announcement: Translational pump priming

The Centre of Excellence in Infectious Diseases Research (CEIDR) is a partnership between the Liverpool School of Tropical Medicine (LSTM) and the University of Liverpool (UoL) focused on translational partnering in infectious diseases to address current and future health priorities. CEIDR aims to become the single portal for external organisations to make connections, source expertise and resources in infectious diseases in Liverpool. CEIDR’s core activities are building relationships with industry and academic organisations to advance drugs, vaccines and diagnostics towards market.

Alongside its operational activities CEIDR aims to enhance the translational potential of high quality research from LSTM and the UoL, targeting unmet market needs in the field of infectious diseases. It will achieve this by providing translational pump priming (CEIDR TPP) funding for new areas of research to LSTM and UoL researchers for collaborative projects between LSTM and UoL and/or clinical partners from the Liverpool City region in the field of infectious diseases. Projects that can demonstrate industry interest or support (in kind or other) are of interest. The aim of the CEIDR TPP funding is to enhance translational potential and can be used to complement recently awarded research funding.

The maximum value of the awards will be £50,000 and applications for smaller grants are encouraged as we are seeking to make a mixture of awards by value. Subject to the quality of applications at least five awards are available in the 2019 round with a start date of 1st September 2019.

Apply Now

The application form can be found here 

Eligibility

Each proposal must be made by at least two co-applicants:

  • The primary applicant must be from either LSTM or UoL and be a clinical or non-clinical investigator at lecturer level[1] or above
  • Applications that include co-applicants from different Liverpool institutions (HEIs and/or NHS Trusts) will receive a higher priority for funding.

A maximum of £50,000 is available for a maximum period of 12-18 months.

CEIDR TPP awards are aimed at stimulating or enhancing new collaborations in the field of infectious diseases and not to renew or continue existing projects. 

Awards are aimed at projects seeking pump priming to develop pilot data to support more substantive grant applications and applicants should identify the call to be targeted following pump priming.

It is acceptable to use CEIDR TPP awards to complement (but not replicate) activities under recently awarded research funding from other schemes

Applicants will have to clearly justify the additional value that will be achieved using the CEIDR TPP funds i.e. how CEIDR TPP support will stimulate new R&D activity as opposed to subsidising what would have taken place anyway.

Awards will only be given to co-applicants who have clearly articulated the translational[2] aspect of the application and who have identified a specific funding call they are targeting for follow-on work. Tangible or in-kind support from industry is not a requirement but evidence of industry interest will be viewed favourably in the assessment of an application.

Eligible costs include salaries, consumables, travel  and access charges for specific facilities.  The purchase of equipment is not allowed under this scheme.

Eligible applications will be subject to peer review by the CEIDR TPP Award Panel, which will be made up of employees of LSTM and the University of Liverpool. The process for assessing applications is provided here.

CEIDR’s policy for managing conflicts of interest is provided here .

Ethical approval must be sought and acquired, where relevant, before funding will be released.

The following reports must be submitted to the CEIDR TPP Award Panel:

  • Interim report at the halfway point of the term of the project; and
  • An Impact Report within three months of the date of completion of the project.

 

[1] For the purposes of this award, we will also consider applications from Tenure Track Fellows
[2] Commercial use, unmet need addressed and route to market